Brief: Pasithea Therapeutics Announces Opening Of Enrollment In The U.S. For Its Phase 1 Trial Of Pas-004
13/02/2024 15:13
Feb 13 (Reuters) - Pasithea Therapeutics Corp KTTA.O :
* PASITHEA THERAPEUTICS ANNOUNCES OPENING OF ENROLLMENT IN
THE
U.S. FOR ITS PHASE 1 TRIAL OF PAS-004
* PRELIMINARY INTERIM DATA EXPECTED IN 2H 2024
* PLANS TO OPEN THREE ADDITIONAL SITES IN EASTERN EUROPE IN
COMING
MONTHS
* PLANS TO OPEN THREE ADDITIONAL SITES IN EASTERN EUROPE IN
COMING
MONTHS
Source text for Eikon: ID:nGNX5SSF5b
Further company coverage: KTTA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Pasithea Therapeutics
See all newsPasithea Therapeutics Corp reports results for the quarter ended June 30 - Earnings Summary
Pasithea Therapeutics Corp expected to post a loss of 16 cents a share - Earnings Preview
Brief: Pasithea Therapeutics Announces Positive Interim Phase 1 Advanced Cancer Study Data
Brief: Pasithea Therapeutics Announces Closing Of $60 Million Public Offering Of Common Stock
Pasithea Therapeutics jumps after $60 million public offering announcement